Schnitzler's Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Schnitzler's Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05200715

AutoInflammatory Disease Alliance Registry (AIDA)

Autoinflammatory diseases (AID) are clinical entities characterized by recurrent inflammatory attacks in absence of infection, neoplasm or deregulation of the a…

Algeria, Australia, Belgium3,500 participantsStarted 2020-08-06

Treatment: No intervention is foreseen by the protocol.

All recent trials (10 shown)

WithdrawnPhase 2

NCT04213274

Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome

The primary goal of the study is to assess the efficacy and safety of RPH-104 in subjects with Schnitzler Syndrome using Schnitzler Disease Activity Score (SDAS…

United States0Started 2023-05

Treatment: 80 mg RPH-104, Placebo

TerminatedPhase 2

NCT03595371

Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome

This is a pilot, open-label Phase 2, single-center, repeat dose, single cohort, proof-of-concept, safety, pharmacodynamics and efficacy study of dapansutrile ca…

Netherlands2 participantsStarted 2018-05-15

Treatment: dapansutrile

Schnitzler's Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

AutoInflammatory Disease Alliance Registry (AIDA)

All recent trials (10 shown)

Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome

Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

AutoInflammatory Disease Alliance Registry (AIDA)

All recent trials (10 shown)

Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome

Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome

Tocilizumab in Patients With Schnitzler's Syndrome

Ilaris (Canakinumab) in the Schnitzler Syndrome

Ilaris® Effects in Schnitzler Syndrome (ILESCH)

Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors

Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

Efficacy and Safety of Canakinumab in Schnitzler Syndrome

The Efficacy and Safety of ITF2357 in AIS